(Q51003945)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663316%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

In vitro study of isoflavones and isoflavans as potent inhibitors of human 12- and 15-lipoxygenases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663316%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Carolina Mascayano

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663316%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Silvia Sepúlveda-Boza

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663316%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Eric K Hoobler

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663316%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

29 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663316%20AND%20SRC:MED&resulttype=core&format=json

Chemical Biology and Drug Design

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663316%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663316%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663316%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

317-325

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663316%20AND%20SRC:MED&resulttype=core&format=json

Mammalian lipoxygenases: molecular structures and functions

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

The diversity of the lipoxygenase family. Many sequence data but little information on biological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Lipoxygenase inhibitors: a comparative QSAR study review and evaluation of new QSARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

The effect of 15-lipoxygenase-1 expression on cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Enhanced angiogenesis and growth of 12-lipoxygenase gene-transfected MCF-7 human breast cancer cells in athymic nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Requirement for epidermal growth factor receptor tyrosine kinase and for 12-lipoxygenase activity in the expression of 12-lipoxygenase in human epidermoid carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Redox inactivation of human 15-lipoxygenase by marine-derived meroditerpenes and synthetic chromanes: archetypes for a unique class of selective and recyclable inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Inhibition of lipoxygenases and cyclooxygenases by linoleyl hydroxamic acid: comparative in vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Hinokitiol, a selective inhibitor of the platelet-type isozyme of arachidonate 12-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Inhibition of 15-lipoxygenases by flavonoids: structure-activity relations and mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Lipoxygenase inhibition by anadanthoflavone, a new flavonoid from the aerial parts of Anadenanthera colubrina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Exploring sponge-derived terpenoids for their potency and selectivity against 12-human, 15-human, and 15-soybean lipoxygenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Probing sponge-derived terpenoids for human 15-lipoxygenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Binding of arachidonic acid and two flavonoid inhibitors to human 12- and 15-lipoxygenases: a steered molecular dynamics study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Lipoxygenase interactions with natural flavonoid, quercetin, reveal a complex with protocatechuic acid in its X-ray structure at 2.1 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Design and synthesis of 4-methoxyphenylacetic acid esters as 15-lipoxygenase inhibitors and SAR comparative studies of them

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

Defining the arachidonic acid binding site of human 15-lipoxygenase. Molecular modeling and mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12157

21 January 2018

Identifiers

DOI

10.1111/CBDD.12157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663316%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference